|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:918-924
© 2002 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease (ACD) |
From the Division of Cardiovascular Surgery, Sendai City Medical Center,a and the Department of Cardiovascular Surgery, Graduate School of Medicine, Tohoku University,b Sendai, Japan.
Received for publication Jan 30, 2002. Revisions requested March 5, 2002; revisions received March 20, 2002. Accepted for publication March 29, 2002. Address for reprints: Yoshimasa Moizumi, MD, the Division of Cardiovascular Surgery, Sendai City Medical Center, 5-22-1 Turugaya, Miyaginoku, Sendai, Miyagi, 983-0824, Japan (E-mail: singe{at}openhp.or.jp).
Objective: Although intramural hematoma of the aorta is considered a unique pathologic entity, the management of intramural hematoma involving the ascending aorta (type A) has not been well established. The purpose of this study was to establish the optimal mode of management of type A intramural hematoma.
Methods: We treated patients with type A intramural hematoma as follows. Early operation was carried out only for patients with cardiac tamponade, impending rupture, or rupture. Other patients were treated medically, but patients with progression of intramural hematoma during medical follow-up had their treatment converted to surgery. From February 1992 to March 2001, a total of 33 patients with type A intramural hematoma were treated as described here. Patients were divided according to initial treatment into an early surgery group (n = 9) and a medical treatment group (n = 24). Clinical profiles and in-hospital and long-term survival rates were compared between the groups.
Results: Compared with the early surgery group, the medical treatment group was younger (64.2 ± 7.0 years vs 71.7 ± 8.5 years, P = .0319) and had a greater number of involved segments (3.6 ± 0.6 vs 3.0 ± 0.9, P = .0395). Eight patients in the medical treatment group were switched to surgery during follow-up because of progression of intramural hematoma. In-hospital mortality rates in the early surgery and medical groups were 11% and 5% (P = .477), respectively. Cumulative 1- and 2-year survivals were 89% and 89%, respectively, in the early surgery group, and 92% and 81%, respectively, in the medical group (P = .49).
Conclusion: We concluded that about 70% of type A intramural hematomas could be managed expectantly, and more than 50% could be treated medically alone.
Related Article
J. Thorac. Cardiovasc. Surg. 2002 124: 894-895.
This article has been cited by other articles:
![]() |
K.-H. Park, C. Lim, J. H. Choi, K. Sung, K. Kim, Y. T. Lee, and P. W. Park Prevalence of Aortic Intimal Defect in Surgically Treated Acute Type A Intramural Hematoma Ann. Thorac. Surg., November 1, 2008; 86(5): 1494 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimokawa, N. Ozawa, S. Takanashi, and T. Itoh Intermediate-Term Results of Surgical Treatment of Acute Intramural Hematoma Involving the Ascending Aorta Ann. Thorac. Surg., March 1, 2008; 85(3): 982 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Svensson, N. T. Kouchoukos, D. C. Miller, J. E. Bavaria, J. S. Coselli, M. A. Curi, H. Eggebrecht, J. A. Elefteriades, R. Erbel, T. G. Gleason, et al. Expert Consensus Document on the Treatment of Descending Thoracic Aortic Disease Using Endovascular Stent-Grafts Ann. Thorac. Surg., January 1, 2008; 85(1_Supplement): S1 - S41. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Sundt Intramural Hematoma and Penetrating Atherosclerotic Ulcer of the Aorta Ann. Thorac. Surg., February 1, 2007; 83(2): S835 - S841. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, T. Onitsuka, M. Yano, Y. Yano, M. Matsuyama, and K. Kojima Clinical analysis of acute type a intramural hematoma: comparison between two different pathophysiological types. Ann. Thorac. Surg., May 1, 2006; 81(5): 1587 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uchida, K. Imoto, M. Takahashi, S.-i. Suzuki, S. Isoda, M. Sugiyama, J. Kondo, and Y. Takanashi Pathologic Characteristics and Surgical Indications of Superacute Type A Intramural Hematoma Ann. Thorac. Surg., May 1, 2005; 79(5): 1518 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Evangelista, D. Mukherjee, R. H. Mehta, P. T. O'Gara, R. Fattori, J. V. Cooper, D. E. Smith, J. K. Oh, S. Hutchison, U. Sechtem, et al. Acute Intramural Hematoma of the Aorta: A Mystery in Evolution Circulation, March 1, 2005; 111(8): 1063 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Cho, A. W. Stanson, D. D. Potter, K. J. Cherry, H. V. Schaff, and T. M. Sundt III Penetrating atherosclerotic ulcer of the descending thoracic aorta and arch J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1393 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Moizumi, T. Komatsu, N. Motoyoshi, and K. Tabayashi Clinical features and long-term outcome of type A and type B intramural hematoma of the aorta J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Motoyoshi, Y. Moizumi, T. Komatsu, and K. Tabayashi Intramural hematoma and dissection involving ascending aorta: the clinical features and prognosis Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 237 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Motoyoshi, T. Komatsu, Y. Moizumi, and K. Tabayashi Atypical paraplegia after aortic intramural hematoma J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 409 - 410. [Full Text] [PDF] |
||||
![]() |
T. M. Sundt Management of intramural hematoma of the ascending aorta: Still room for debate J. Thorac. Cardiovasc. Surg., November 1, 2002; 124(5): 894 - 895. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |